Dimitrios C Ladakis

Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis

P. Bhargava, S. Saidha, P. Calabresi, 2022, Multiple sclerosis.

The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis

P. Bhargava, Dimitrios C Ladakis, 2023, CNS Drugs.

Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis

P. Bhargava, E. Waubant, J. Newman, 2023, Multiple sclerosis.

Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease

P. Bhargava, K. Fitzgerald, E. Sotirchos, 2022, Multiple sclerosis journal - experimental, translational and clinical.

Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis

P. Bhargava, S. Saidha, Matthew D. Smith, 2023, Multiple sclerosis.

Distinct plasma lipids predict axonal injury and multiple sclerosis activity.

J. Tillema, Aaron W Abrams, S. Mar, 2024, Journal of neurology, neurosurgery, and psychiatry.

Ocrelizumab alters the circulating metabolome in people with relapsing-remitting multiple sclerosis.

P. Bhargava, B. Nourbakhsh, Dimitrios C Ladakis, 2024, Annals of clinical and translational neurology.

Characterization of spinal cord tissue-derived extracellular vesicles in neuroinflammation

P. Bhargava, K. Witwer, Matthew D. Smith, 2024, Journal of neuroinflammation.